Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: PSF

Enterprise Safety Technology Helps LA Businesses Reopen Safely


SANTA MONICA, Calif., June 30, 2020 /PRNewswire/ -- Fuel Cycle, Inc., a technology leader in market research and experience management, is the first business in Los Angeles to reopen with Vitalacy's workplace safety technology.

Fuel Cycle Human Resources Director, Yami Rodriguez was searching for a way to keep staff safe while offices slowly reopened. "We needed to ensure our business strategy was complying with CDC's guidelines of promoting safe social distancing and proper hand hygiene," Rodriguez shared. "Coming back to work in an office can be an understandable concern for our employees and their families. It was important for us to invest in measures to help reduce risk of exposure." 

While at work, Fuel Cycle employees wear a Vitalacy SmartBand. The device measures proximity to other SmartBands in the office. If they are maintaining an unsafe proximity with other employees, the users they interacted with (for too close for too long) are notified by Vitalacy that they may have been exposed. The SmartBand also reminds wearers to hand wash every hour. The solution does not track user location and keeps all user data anonymous from other team members and their employer. 

Vitalacy was recently awarded Newsweek's Best in HealthCare 2020 as one of the best monitoring products for infection prevention. The technology improves how often and how well health care workers wash their hands to lower risk of hospital-acquired infections and keep both caregivers and patients safe.

"We quickly realized our platform designed to help hospitals prevent the spread of infection could be used to help the workplace prevent the spread of COVID-19," said Janel Nour-Omid, Vitalacy CEO and Cofounder. "We are honored to be incorporated into Fuel Cycle's employee safety plan and help Los Angeles reopen responsibly." Nour-Omid was awarded Forbes 30 Under 30 in Healthcare for 2020.

Vitalacy has partnered with additional SOCAL businesses currently trialing the solution this summer.

"Only together as a team can we help reduce risk of exposure for our employees as we manage workplace safety and maintain confidence during these difficult times," said Eran Gilad, CEO of Fuel Cycle. 

Learn More: www.vitalacy.com/contact-tracing

About Fuel Cycle
Fuel Cycle is a technology leader in market research and experience management, headquartered in Los Angeles. The Fuel Cycle Market Research Cloud connects companies with their products, brand, customers and employees and powers the world's most customer-centric brands.

About Vitalacy
Vitalacy, Inc. is a patient safety technology company based in Los Angeles, California. Our powerful and durable location-based platform automates workflow and compliance monitoring so hospitals can better focus on patient outcomes and caregiver well-being.

CONTACT: Haley Dukelow, 714 486 9244, [email protected]

SOURCE Vitalacy


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: